Table 1.
Clinical characteristics of patients presenting with AECOPD
| Characteristics | Number (%) |
|---|---|
| Gender | |
| Male | 77 (50) |
| Female | 76 (50) |
| Baseline COPD severity | |
| Mild | 5 (3) |
| Moderate | 16 (10) |
| Severe | 43 (28) |
| Very severe | 29 (19) |
| Unknown | 60 (39) |
| Influenza‐like symptoms | |
| Yes | 75 (49) |
| No | 78 (51) |
| CXR consolidation | |
| Yes | 53 (35) |
| No | 100 (65) |
| Viral NPA requested | |
| Yes | 102 (67) |
| No | 51 (33) |
| Inflammatory markers requested | |
| CRP | 94 (61) |
| Pro‐calcitonin | 6 (6) |
| Empirical antibiotics commenced | |
| Yes | 151 (99) |
| No | 2 (1) |
| Empirical antivirals commenced | |
| Yes | 15 (10) |
| No | 138 (90) |
| Isolation | |
| Yes | 45 (29) |
| No | 108 (71) |
AECOPD, acute exacerbations of chronic obstructive pulmonary disease; COPD, Chronic obstructive pulmonary disease; CRP, C‐reactive protein; CXR; NPA, nasopharyngeal aspirate.